Am J Psychiatry 156:646-649, April 1999
© 1999 American Psychiatric Association
Double-Blind Treatment of Major Depression With Dehydroepiandrosterone
Owen M. Wolkowitz, M.D.,
Victor I. Reus, M.D.,
Audrey Keebler, B.A.,
Nicola Nelson, B.A.,
Mirit Friedland, B.A.,
Louann Brizendine, M.D., and
Eugene Roberts, Ph.D.
OBJECTIVE: This study was designed to assess possible antidepressant effects of dehydroepiandrosterone (DHEA), an abundant adrenocortical hormone in humans. METHOD: Twenty-two patients with major depression, either medication-free or on stabilized antidepressant regimens, received either DHEA (maximum dose=90 mg/day) or placebo for 6 weeks in a double-blind manner and were rated at baseline and at the end of the 6 weeks with the Hamilton Depression Rating Scale. Patients previously stabilized with antidepressants had the study medication added to that regimen; others received DHEA or placebo alone. RESULTS: DHEA was associated with a significantly greater decrease in Hamilton depression scale ratings than was placebo. Five of the 11 patients treated with DHEA, compared with none of the 11 given placebo, showed a 50% decrease or greater in depressive symptoms. CONCLUSIONS: These results suggest that DHEA treatment may have significant antidepressant effects in some patients with major depression. Further, larger-scale trials are warranted.
This article has been cited by other articles:
|
|
|
|
 
S. A. McIsaac, A. Westrin, and A. H. Young
Antiglucocorticoids in psychiatry
Advan. Psychiatr. Treat.,
July 1, 2009;
15(4):
242 - 249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Claes
Targeting the HPA axis in major depression: does it work?: INVITED COMMENTARY ON... ANTIGLUCOCORTICOIDS IN PSYCHIATRY
Advan. Psychiatr. Treat.,
July 1, 2009;
15(4):
250 - 252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A Hartkamp, R Geenen, G L R Godaert, H Bootsma, A A Kruize, J W J Bijlsma, and R H W M Derksen
Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial
Ann Rheum Dis,
January 1, 2008;
67(1):
91 - 97.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Panjari and S. R. Davis
DHEA therapy for women: effect on sexual function and wellbeing
Hum. Reprod. Update,
May 1, 2007;
13(3):
239 - 248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Brooke, L. A. Kalingag, F. Miraki-Moud, C. Camacho-Hubner, K. T. Maher, D. M. Walker, J. P. Hinson, and J. P. Monson
Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement
J. Clin. Endocrinol. Metab.,
October 1, 2006;
91(10):
3773 - 3779.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Rabkin, M. C. McElhiney, R. Rabkin, P. J. McGrath, and S. J. Ferrando
Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) for Treatment of Nonmajor Depression in Patients With HIV/AIDS
Am J Psychiatry,
January 1, 2006;
163(1):
59 - 66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Schmidt, R. C. Daly, M. Bloch, M. J. Smith, M. A. Danaceau, L. Simpson St. Clair, J. H. Murphy, N. Haq, and D. R. Rubinow
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Arch Gen Psychiatry,
February 1, 2005;
62(2):
154 - 162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Jahn, M. Schick, F. Kiefer, M. Kellner, A. Yassouridis, and K. Wiedemann
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Arch Gen Psychiatry,
December 1, 2004;
61(12):
1235 - 1244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney
Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress
Focus,
July 1, 2004;
2(3):
368 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Valenti, L. Denti, M. Maggio, G. Ceda, S. Volpato, S. Bandinelli, G. Ceresini, A. Cappola, J. M. Guralnik, and L. Ferrucci
Effect of DHEAS on Skeletal Muscle Over the Life Span: The InCHIANTI Study
J. Gerontol. A Biol. Sci. Med. Sci.,
May 1, 2004;
59(5):
M466 - M472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Soma, N. A. Alday, M. Hau, and B. A. Schlinger
Dehydroepiandrosterone Metabolism by 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase in Adult Zebra Finch Brain: Sex Difference and Rapid Effect of Stress
Endocrinology,
April 1, 2004;
145(4):
1668 - 1677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney
Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress
Am J Psychiatry,
February 1, 2004;
161(2):
195 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Dhatariya and K. S. Nair
Dehydroepiandrosterone: Is There a Role for Replacement?
Mayo Clin. Proc.,
October 1, 2003;
78(10):
1257 - 1273.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O.M. Wolkowitz, J.H. Kramer, V.I. Reus, M.M. Costa, K. Yaffe, P. Walton, M. Raskind, E. Peskind, P. Newhouse, D. Sack, et al.
DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled study
Neurology,
April 8, 2003;
60(7):
1071 - 1076.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zuess
An Integrative Approach to Depression: Part 2--Assessment and Treatment
Complementary Health Practice Review,
April 1, 2003;
8(2):
99 - 115.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier
Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
Endocr. Rev.,
April 1, 2003;
24(2):
152 - 182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Cleare
The Neuroendocrinology of Chronic Fatigue Syndrome
Endocr. Rev.,
April 1, 2003;
24(2):
236 - 252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Strous, R. Maayan, R. Lapidus, R. Stryjer, M. Lustig, M. Kotler, and A. Weizman
Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia
Arch Gen Psychiatry,
February 1, 2003;
60(2):
133 - 141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Young, P. Gallagher, and R. J. Porter
Elevation of the Cortisol-Dehydroepiandrosterone Ratio in Drug-Free Depressed Patients
Am J Psychiatry,
July 1, 2002;
159(7):
1237 - 1239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Emanuel, T. R. Moore, and P. Ghazvini
Considerations for the Use of Alternative Therapies in the Treatment of Depression
Journal of Pharmacy Practice,
December 1, 2001;
14(6):
551 - 559.
[Abstract]
[PDF]
|
|
|
|
|
|
|
W. Arlt, F. Callies, I. Koehler, J. C. van Vlijmen, M. Fassnacht, C. J. Strasburger, M. J. Seibel, D. Huebler, M. Ernst, M. Oettel, et al.
Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion
J. Clin. Endocrinol. Metab.,
October 1, 2001;
86(10):
4686 - 4692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Urani, F. J. Roman, V.-L. Phan, T.-P. Su, and T. Maurice
The Antidepressant-Like Effect Induced by sigma 1-Receptor Agonists and Neuroactive Steroids in Mice Submitted to the Forced Swimming Test
J. Pharmacol. Exp. Ther.,
September 1, 2001;
298(3):
1269 - 1279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Crone, G. Gabriel, and T. N. Wise
Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Psychosomatics,
August 1, 2001;
42(4):
285 - 299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Monteleone, M. Luisi, B. Colurcio, E. Casarosa, P. Monteleone, R. Ioime, A. R. Genazzani, and M. Maj
Plasma Levels of Neuroactive Steroids Are Increased in Untreated Women With Anorexia Nervosa or Bulimia Nervosa
Psychosom Med,
January 1, 2001;
63(1):
62 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Hunt, E. M. Gurnell, F. A. Huppert, C. Richards, A. T. Prevost, J. A. H. Wass, J. Herbert, and V. K. K. Chatterjee
Improvement in Mood and Fatigue after Dehydroepiandrosterone Replacement in Addison's Disease in a Randomized, Double Blind Trial
J. Clin. Endocrinol. Metab.,
December 1, 2000;
85(12):
4650 - 4656.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. McQUADE and A. H. Y. YOUNG
Future therapeutic targets in mood disorders: the glucocorticoid receptor
The British Journal of Psychiatry,
November 1, 2000;
177(5):
390 - 395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Oelkers
Dehydroepiandrosterone for Adrenal Insufficiency
N. Engl. J. Med.,
September 30, 1999;
341(14):
1073 - 1074.
[Full Text]
|
|
|
|
|
|
|
O. M. Wolkowitz and V. I. Reus
Treatment of Depression With Antiglucocorticoid Drugs
Psychosom Med,
September 1, 1999;
61(5):
698 - 711.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
